Basic Information
RNALocate ID: | RLID:11002010 |
RNA Symbol: | hsa-miR-320a-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-320a |
RNA ID: | miRBase:MIMAT0000510 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 25330373 |
Tissue/Cell Line: | Colon cancer cell line (LIM1863) |
Method: | qRT-PCR|RNA sequencing |
Description: | To assess whether some miRNAs are specifically sorted into EVs we conducted a miRNA-enrichment analysis for A33-Exos, EpCAM-Exos and sMVs. MiRNAs with <2 fold changes relative to CL miRNAs were filtered out, yielding 63 miRNAs for comparison (Table 2). Data are collected from Table 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001858 | Cytoplasm | Cardiomyocytes | 31837603 |
RLID:01001859 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001860 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001861 | Mitochondrion | HEK-293 cells|HeLa cells | 27396686 |
RLID:01001862 | Mitochondrion | HEK-293 cells|HeLa cells | 27563705 |
RLID:01001863 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001864 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001865 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001866 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001867 | Nucleus | Cardiomyocytes | 31837603 |
RLID:01001868 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001869 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11001998 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11001999 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
RLID:11002000 | Exosome | Pooled sera | 27278097 |
RLID:11002001 | Exosome | Serum | 18589210 |
RLID:11002002 | Exosome | Glioblastoma cells | 19011622 |
RLID:11002003 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11002004 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11002005 | Exosome | Brain tissue | 23382797 |
RLID:11002006 | Exosome | Plasma | 23663360 |
RLID:11002007 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002008 | Exosome | Serum | 25135963 |
RLID:11002009 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11002011 | Exosome | Cerebrospinal fluid | 25420022 |
RLID:11002012 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11002013 | Microvesicle | Glioblastoma cells | 19011622 |
RLID:11002014 | Microvesicle | Plasma | 23077538 |
RLID:11002015 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002016 | Microvesicle | Follicular fluid | 23666971 |
RLID:11002017 | Microvesicle | Serum | 24797360 |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-320a-3p | Cardiomyopathy | MNDR-E-MI-39294 |
MNDR | hsa-miR-320a-3p | Diffuse large b cell lymphoma | MNDR-E-MI-39295 |
MNDR | hsa-miR-320a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-39296 |
MNDR | hsa-miR-320a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-39297 |
MNDR | hsa-miR-320a-3p | Follicular lymphoma | MNDR-E-MI-39298 |
MNDR | hsa-miR-320a-3p | Medulloblastoma | MNDR-E-MI-39299 |
MNDR | hsa-miR-320a-3p | Lymphoma | MNDR-E-MI-39300 |
MNDR | hsa-miR-320a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-39301 |
MNDR | hsa-miR-320a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-39302 |
MNDR | hsa-miR-320a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-39303 |
MNDR | hsa-miR-320a-3p | Breast cancer luminal | MNDR-E-MI-39304 |
MNDR | hsa-miR-320a-3p | Lupus nephritis | MNDR-E-MI-39305 |
MNDR | hsa-miR-320a-3p | Prostate cancer | MNDR-E-MI-39306 |
MNDR | hsa-miR-320a-3p | Alzheimer disease | MNDR-E-MI-39307 |
MNDR | hsa-miR-320a-3p | Sickle cell anemia | MNDR-E-MI-39308 |
MNDR | hsa-miR-320a-3p | Ataxia telangiectasia | MNDR-E-MI-39309 |
MNDR | hsa-miR-320a-3p | Lung cancer | MNDR-E-MI-39310 |
MNDR | hsa-miR-320a-3p | Parkinson disease | MNDR-E-MI-39311 |
MNDR | hsa-miR-320a-3p | Breast cancer | MNDR-E-MI-39312 |
MNDR | hsa-miR-320a-3p | Pituitary neoplasms | MNDR-E-MI-39313 |
MNDR | hsa-miR-320a-3p | Pancreatic cancer | MNDR-E-MI-39314 |
MNDR | hsa-miR-320a-3p | Melanoma | MNDR-E-MI-39315 |
MNDR | hsa-miR-320a-3p | Wilms tumor | MNDR-E-MI-39316 |
MNDR | hsa-miR-320a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-39317 |
MNDR | hsa-miR-320a-3p | Ovarian neoplasms | MNDR-E-MI-39318 |
MNDR | hsa-miR-320a-3p | Kidney cancer | MNDR-E-MI-39319 |
MNDR | hsa-miR-320a-3p | Glioblastoma | MNDR-E-MI-39320 |
MNDR | hsa-miR-320a-3p | Astrocytoma | MNDR-E-MI-39321 |
MNDR | hsa-miR-320a-3p | Glioma | MNDR-E-MI-39322 |
MNDR | hsa-miR-320a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-39323 |
MNDR | hsa-miR-320a-3p | Osteosarcoma | MNDR-E-MI-39324 |
MNDR | hsa-miR-320a-3p | Inclusion body myositis | MNDR-E-MI-39325 |
MNDR | hsa-miR-320a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39326 |
MNDR | hsa-miR-320a-3p | Uterus cancer | MNDR-E-MI-39327 |
MNDR | hsa-miR-320a-3p | Pituitary adenoma | MNDR-E-MI-39328 |
MNDR | hsa-miR-320a-3p | Lung squamous cell carcinoma | MNDR-E-MI-39329 |
MNDR | hsa-miR-320a-3p | Non-small cell lung cancer | MNDR-E-MI-39330 |
MNDR | hsa-miR-320a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-39331 |
MNDR | hsa-miR-320a-3p | Cholangiocarcinoma | MNDR-E-MI-39332 |
MNDR | hsa-miR-320a-3p | Esophageal cancer | MNDR-E-MI-39333 |
MNDR | hsa-miR-320a-3p | Encephalopathy bovine spongiform | MNDR-E-MI-39334 |
MNDR | hsa-miR-320a-3p | Heart failure | MNDR-E-MI-39335 |
MNDR | hsa-miR-320a-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-39336 |
MNDR | hsa-miR-320a-3p | Encephalomyelitis | MNDR-E-MI-39337 |
MNDR | hsa-miR-320a-3p | Leukoencephalopathy progressive multifocal | MNDR-E-MI-39338 |
MNDR | hsa-miR-320a-3p | Hepatocellular carcinoma | MNDR-E-MI-39339 |
MNDR | hsa-miR-320a-3p | B-cell lymphoma | MNDR-E-MI-39340 |
MNDR | hsa-miR-320a-3p | Malignant pleural mesothelioma | MNDR-E-MI-39341 |
MNDR | hsa-miR-320a-3p | Retinoblastoma | MNDR-E-MI-39342 |
MNDR | hsa-miR-320a-3p | Neuroblastoma | MNDR-E-MI-39343 |
MNDR | hsa-miR-320a-3p | Burkitt lymphoma | MNDR-E-MI-39344 |
MNDR | hsa-miR-320a-3p | Acute myeloid leukemia | MNDR-E-MI-39345 |
MNDR | hsa-miR-320a-3p | Colorectal cancer | MNDR-E-MI-39346 |
MNDR | hsa-miR-320a-3p | Multiple myeloma | MNDR-E-MI-39347 |
MNDR | hsa-miR-320a-3p | Acute lymphocytic leukemia | MNDR-E-MI-39348 |
MNDR | hsa-miR-320a-3p | Nasopharyngeal cancer | MNDR-E-MI-39349 |
MNDR | hsa-miR-320a-3p | Nerve degeneration | MNDR-E-MI-39350 |
MNDR | hsa-miR-320a-3p | Prostatic neoplasms | MNDR-E-MI-39351 |
MNDR | hsa-miR-320a-3p | Reperfusion injury | MNDR-E-MI-39352 |
MNDR | hsa-miR-320a-3p | Chronic pain | MNDR-E-MI-39353 |
MNDR | hsa-miR-320a-3p | Barrett's carcinogenesis | MNDR-E-MI-39354 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCG2 | Homo sapiens | RR00024747 |
TOP